Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients
Clinical trial NCT01215513 · COMPLETED
Trial details
- NCT number
- NCT01215513
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-04-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.